The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. / Gislason, Gunnar H.; Rasmussen, Jeppe N.; Abildstrom, Steen Z.; Rasmussen, Soren; Schramm, Tina K.; Folke, Fredrik; Hansen, Morten L.; Kober, Lars; Madsen, Mette; Torp-Pedersen, Christian.

I: Circulation, Bind 116, Nr. 16, 16.10.2007, s. 736-736.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Gislason, GH, Rasmussen, JN, Abildstrom, SZ, Rasmussen, S, Schramm, TK, Folke, F, Hansen, ML, Kober, L, Madsen, M & Torp-Pedersen, C 2007, 'The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure', Circulation, bind 116, nr. 16, s. 736-736.

APA

Gislason, G. H., Rasmussen, J. N., Abildstrom, S. Z., Rasmussen, S., Schramm, T. K., Folke, F., Hansen, M. L., Kober, L., Madsen, M., & Torp-Pedersen, C. (2007). The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. Circulation, 116(16), 736-736.

Vancouver

Gislason GH, Rasmussen JN, Abildstrom SZ, Rasmussen S, Schramm TK, Folke F o.a. The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. Circulation. 2007 okt. 16;116(16):736-736.

Author

Gislason, Gunnar H. ; Rasmussen, Jeppe N. ; Abildstrom, Steen Z. ; Rasmussen, Soren ; Schramm, Tina K. ; Folke, Fredrik ; Hansen, Morten L. ; Kober, Lars ; Madsen, Mette ; Torp-Pedersen, Christian. / The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure. I: Circulation. 2007 ; Bind 116, Nr. 16. s. 736-736.

Bibtex

@article{bc02ce835911432992308e636ec359a8,
title = "The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure",
author = "Gislason, {Gunnar H.} and Rasmussen, {Jeppe N.} and Abildstrom, {Steen Z.} and Soren Rasmussen and Schramm, {Tina K.} and Fredrik Folke and Hansen, {Morten L.} and Lars Kober and Mette Madsen and Christian Torp-Pedersen",
year = "2007",
month = oct,
day = "16",
language = "English",
volume = "116",
pages = "736--736",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams & Wilkins",
number = "16",

}

RIS

TY - JOUR

T1 - The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

AU - Gislason, Gunnar H.

AU - Rasmussen, Jeppe N.

AU - Abildstrom, Steen Z.

AU - Rasmussen, Soren

AU - Schramm, Tina K.

AU - Folke, Fredrik

AU - Hansen, Morten L.

AU - Kober, Lars

AU - Madsen, Mette

AU - Torp-Pedersen, Christian

PY - 2007/10/16

Y1 - 2007/10/16

M3 - Journal article

VL - 116

SP - 736

EP - 736

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -

ID: 93940610